# Nicotinamide Mononucleotide in Hypertensive Patients

> **NCT04903210** · PHASE4 · UNKNOWN · sponsor: **First Affiliated Hospital, Sun Yat-Sen University** · enrollment: 20 (estimated)

## Conditions studied

- Hypertension

## Interventions

- **DIETARY_SUPPLEMENT:** Nicotinamide mononucleotide supplied as 400mg capsule
- **BEHAVIORAL:** Lifestyle modification

## Key facts

- **NCT ID:** NCT04903210
- **Lead sponsor:** First Affiliated Hospital, Sun Yat-Sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-06-01
- **Primary completion:** 2022-06-20
- **Final completion:** 2022-07-31
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2022-02-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04903210

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04903210, "Nicotinamide Mononucleotide in Hypertensive Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04903210. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*